Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cells ; 10(9)2021 08 27.
Article in English | MEDLINE | ID: mdl-34571865

ABSTRACT

Leprosy reactional episodes are acute inflammatory events that may occur during the clinical course of the disease. Type 1 reaction (T1R) is associated with an increase in neural damage, and the understanding of the molecular pathways related to T1R onset is pivotal for the development of strategies that may effectively control the reaction. Interferon-gamma (IFN-γ) is a key cytokine associated with T1R onset and is also associated with autophagy induction. Here, we evaluated the modulation of the autophagy pathway in Mycobacterium leprae-stimulated cells in the presence or absence of IFN-γ. We observed that IFN-γ treatment promoted autophagy activation and increased the expression of genes related to the formation of phagosomes, autophagy regulation and function, or lysosomal pathways in M. leprae-stimulated cells. IFN-γ increased interleukin (IL)-15 secretion in M. leprae-stimulated THP-1 cells in a process associated with autophagy activation. We also observed higher IL15 gene expression in multibacillary (MB) patients who later developed T1R during clinical follow-up when compared to MB patients who did not develop the episode. By overlapping gene expression patterns, we observed 13 common elements shared between T1R skin lesion cells and THP-1 cells stimulated with both M. leprae and IFN-γ. Among these genes, the autophagy regulator Translocated Promoter Region, Nuclear Basket Protein (TPR) was significantly increased in T1R cells when compared with non-reactional MB cells. Overall, our results indicate that IFN-γ may induce a TPR-mediated autophagy transcriptional program in M. leprae-stimulated cells similar to that observed in skin cells during T1R by a pathway that involves IL-15 production, suggesting the involvement of this cytokine in the pathogenesis of T1R.


Subject(s)
Autophagy/genetics , Interleukin-15/genetics , Leprosy/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Cells, Cultured , Child , Cytokines/genetics , Female , Gene Expression/genetics , Humans , Interferon-gamma/genetics , Leprosy/microbiology , Male , Middle Aged , Mycobacterium leprae/pathogenicity , Skin/metabolism , Skin/microbiology , THP-1 Cells/metabolism , Young Adult
2.
PLoS Negl Trop Dis ; 11(7): e0005754, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28715406

ABSTRACT

The pathways that trigger exacerbated immune reactions in leprosy could be determined by genetic variations. Here, in a prospective approach, both genetic and non-genetic variables influencing the amount of time before the development of reactional episodes were studied using Kaplan-Meier survival curves, and the genetic effect was estimated by the Cox proportional-hazards regression model. In a sample including 447 leprosy patients, we confirmed that gender (male), and high bacillary clinical forms are risk factors for leprosy reactions. From the 15 single nucleotide polymorphisms (SNPs) at the 8 candidate genes genotyped (TNF/LTA, IFNG, IL10, TLR1, NOD2, SOD2, and IL6) we observed statistically different survival curves for rs751271 at the NOD2 and rs2069845 at the IL6 genes (log-rank p-values = 0.002 and 0.023, respectively), suggesting an influence on the amount of time before developing leprosy reactions. Cox models showed associations between the SNPs rs751271 at NOD2 and rs2069845 at IL6 with leprosy reactions (HRGT = 0.45, p = 0.002; HRAG = 1.88, p = 0.0008, respectively). Finally, IL-6 and IFN-γ levels were confirmed as high, while IL-10 titers were low in the sera of reactional patients. Rs751271-GT genotype-bearing individuals correlated (p = 0.05) with lower levels of IL-6 in sera samples, corroborating the genetic results. Although the experimental size may be considered a limitation of the study, the findings confirm the association of classical variables such as sex and clinical forms with leprosy, demonstrating the consistency of the results. From the results, we conclude that SNPs at the NOD2 and IL6 genes are associated with leprosy reactions as an outcome. NOD2 also has a clear functional pro-inflammatory link that is coherent with the exacerbated responses observed in these patients.


Subject(s)
Genetic Predisposition to Disease , Inflammation/pathology , Interleukin-6/genetics , Leprosy/pathology , Nod2 Signaling Adaptor Protein/genetics , Polymorphism, Single Nucleotide , Adult , Cohort Studies , Female , Humans , Inflammation/genetics , Leprosy/genetics , Male , Middle Aged , Risk Factors
3.
PLoS Pathog ; 13(1): e1006103, 2017 01.
Article in English | MEDLINE | ID: mdl-28056107

ABSTRACT

Leprosy is a chronic infectious disease that may present different clinical forms according to the immune response of the host. Levels of IFN-γ are significantly raised in paucibacillary tuberculoid (T-lep) when compared with multibacillary lepromatous (L-lep) patients. IFN-γ primes macrophages for inflammatory activation and induces the autophagy antimicrobial mechanism. The involvement of autophagy in the immune response against Mycobacterium leprae remains unexplored. Here, we demonstrated by different autophagic assays that LC3-positive autophagosomes were predominantly observed in T-lep when compared with L-lep lesions and skin-derived macrophages. Accumulation of the autophagic receptors SQSTM1/p62 and NBR1, expression of lysosomal antimicrobial peptides and colocalization analysis of autolysosomes revealed an impairment of the autophagic flux in L-lep cells, which was restored by IFN-γ or rapamycin treatment. Autophagy PCR array gene-expression analysis revealed a significantly upregulation of autophagy genes (BECN1, GPSM3, ATG14, APOL1, and TPR) in T-lep cells. Furthermore, an upregulation of autophagy genes (TPR, GFI1B and GNAI3) as well as LC3 levels was observed in cells of L-lep patients that developed type 1 reaction (T1R) episodes, an acute inflammatory condition associated with increased IFN-γ levels. Finally, we observed increased BCL2 expression in L-lep cells that could be responsible for the blockage of BECN1-mediated autophagy. In addition, in vitro studies demonstrated that dead, but not live M. leprae can induce autophagy in primary and lineage human monocytes, and that live mycobacteria can reduce the autophagy activation triggered by dead mycobacteria, suggesting that M. leprae may hamper the autophagic machinery as an immune escape mechanism. Together, these results indicate that autophagy is an important innate mechanism associated with the M. leprae control in skin macrophages.


Subject(s)
Autophagy/physiology , Leprosy/immunology , Skin/microbiology , Adult , Aged , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Interferon-gamma/immunology , Leprosy/pathology , Macrophages/immunology , Male , Microscopy, Electron, Transmission , Middle Aged , Mycobacterium leprae/immunology , Polymerase Chain Reaction , Skin/immunology , Skin/pathology , Transcriptome , Young Adult
4.
s.l; Elsevier; 2017. 10 p. tab, graf.
Non-conventional in English | HANSEN, Sec. Est. Saúde SP, Hanseníase Leprosy, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1052567

ABSTRACT

Our previous study has demonstrated that IL-10 may modulate both indoleamine 2,3-dioxygenase (IDO) and CD163 expression in lepromatous leprosy (LL) cells, favoring Mycobacterium leprae persistence through induction of regulatory pathways and iron storage. Here, we observed that in LL lesion cells there is an increase in the expression of proteins involved in iron metabolism such as hemoglobin (Hb), haptoglobin, heme oxygenase 1 and transferrin receptor 1 (TfR1) when compared to tuberculoid leprosy (BT) cells. We also found increased iron deposits and diminished expression of the iron exporter ferroportin 1 in LL lesion cells. Hemin, but not FeSO stimulation, was able to enhance M. leprae viability by a mechanism that involves IDO. Analysis of cell phenotype in lesions demonstrated a predominance of M2 markers in LL when compared with BT lesion cells. A positive correlation between CD163 and PPARG with the bacillary index (BI) was observed. In contrast, TNF, STAT1 and CSF2 presented a negative correlation with the BI. In summary, this study demonstrates that iron may regulate IDO expression by a mechanism that involves IL-10, which may contribute for the predominance of M2-like phenotype in LL lesions that favors the phagocytosis and maintenance of M. leprae in host cells.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Immunoblotting , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/microbiology , Immunoenzyme Techniques , Reverse Transcriptase Polymerase Chain Reaction , Indoleamine-Pyrrole 2,3,-Dioxygenase/physiology , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Iron/physiology , Iron/metabolism , Mycobacterium leprae/physiology , Mycobacterium leprae/metabolism
5.
s.l; s.n; 2017. 29 p. tab, graf.
Non-conventional in English | HANSEN, Sec. Est. Saúde SP, Hanseníase Leprosy | ID: biblio-1053527

ABSTRACT

Leprosy is a chronic infectious disease that may present different clinical forms according to the immune response of the host. Levels of IFN-γ are significantly raised in paucibacillary tuberculoid (T-lep) when compared with multibacillary lepromatous (L-lep) patients. IFN-γ primes macrophages for inflammatory activation and induces the autophagy antimicrobial mechanism. The involvement of autophagy in the immune response against Mycobacterium leprae remains unexplored. Here, we demonstrated by different autophagic assays that LC3-positive autophagosomes were predominantly observed in T-lep when compared with L-lep lesions and skin-derived macrophages. Accumulation of the autophagic receptors SQSTM1/p62 and NBR1, expression of lysosomal antimicrobial peptides and colocalization analysis of autolysosomes revealed an impairment of the autophagic flux in L-lep cells, which was restored by IFN-γ or rapamycin treatment. Autophagy PCR array gene-expression analysis revealed a significantly upregulation of autophagy genes (BECN1, GPSM3, ATG14, APOL1, and TPR) in T-lep cells. Furthermore, an upregulation of autophagy genes (TPR, GFI1B and GNAI3) as well as LC3 levels was observed in cells of L-lep patients that developed type 1 reaction (T1R) episodes, an acute inflammatory condition associated with increased IFN-γ levels. Finally, we observed increased BCL2 expression in L-lep cells that could be responsible for the blockage of BECN1-mediated autophagy. In addition, in vitro studies demonstrated that dead, but not live M. leprae can induce autophagy in primary and lineage human monocytes, and that live mycobacteria can reduce the autophagy activation triggered by dead mycobacteria, suggesting that M. leprae may hamper the autophagic machinery as an immune escape mechanism. Together, these results indicate that autophagy is an important innate mechanism associated with the M. leprae control in skin macrophages.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Young Adult , Skin/immunology , Skin/microbiology , Skin/pathology , Autophagy/physiology , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Blotting, Western , Polymerase Chain Reaction , Fluorescent Antibody Technique , Interferon-gamma/immunology , Microscopy, Electron, Transmission , Transcriptome , Leprosy/immunology , Leprosy/pathology , Macrophages/immunology , Mycobacterium leprae/immunology
6.
PLoS Negl Trop Dis ; 10(8): e0004955, 2016 08.
Article in English | MEDLINE | ID: mdl-27556927

ABSTRACT

Erythema Nodosum Leprosum (ENL) is an immune reaction in leprosy that aggravates the patient´s clinical condition. ENL presents systemic symptoms of an acute infectious syndrome with high leukocytosis and intense malaise clinically similar to sepsis. The treatment of ENL patients requires immunosuppression and thus needs to be early and efficient to prevent both disabilities and permanent nerve damage. Some patients experience multiple episodes of ENL and prolonged use of immunosuppressive drugs may lead to serious adverse effects. Thalidomide treatment is extremely effective at ameliorating ENL symptoms. Several mechanisms have been proposed to explain the efficacy of thalidomide in ENL, including the inhibition of TNF production. Given its teratogenicity, thalidomide is prohibitive for women of childbearing age. A rational search for molecular targets during ENL episodes is essential to better understand the disease mechanisms involved, which may also lead to the discovery of new drugs and diagnostic tests. Previous studies have demonstrated that IFN-γ and GM-CSF, involved in the induction of CD64 expression, increase during ENL. The aim of the present study was to investigate CD64 expression during ENL and whether thalidomide treatment modulated its expression. Leprosy patients were allocated to one of five groups: (1) Lepromatous leprosy, (2) Borderline leprosy, (3) Reversal reaction, (4) ENL, and (5) ENL 7 days after thalidomide treatment. The present study demonstrated that CD64 mRNA and protein were expressed in ENL lesions and that thalidomide treatment reduced CD64 expression and neutrophil infiltrates-a hallmark of ENL. We also showed that ENL blood neutrophils exclusively expressed CD64 on the cell surface and that thalidomide diminished overall expression. Patient classification based on clinical symptoms found that severe ENL presented high levels of neutrophil CD64. Collectively, these data revealed that ENL neutrophils express CD64, presumably contributing to the immunopathogenesis of the disease.


Subject(s)
Erythema Nodosum/immunology , Leprostatic Agents/therapeutic use , Neutrophils/drug effects , Neutrophils/immunology , Receptors, IgG/genetics , Thalidomide/therapeutic use , Adolescent , Adult , Aged , Biopsy , Erythema Nodosum/diagnosis , Erythema Nodosum/drug therapy , Erythema Nodosum/microbiology , Female , Humans , Leprosy, Borderline/drug therapy , Leprosy, Borderline/immunology , Leprosy, Borderline/microbiology , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/immunology , Leprosy, Lepromatous/microbiology , Male , Middle Aged , Receptors, IgG/immunology , Skin/microbiology , Skin/pathology , Young Adult
7.
Expert Rev Clin Immunol ; 11(3): 391-407, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25666357

ABSTRACT

Type 1 reaction (T1R) or reversal reaction is the leading cause of physical disabilities and deformities in leprosy. Leprosy patients, even after being considered cured and released from treatment, may suffer from reactional episodes for long periods of time. Early diagnosis is a great challenge for effectively treating and managing T1R. There is an urgent need to identify the most significant biomarkers to prevent recurrent T1R and to differentiate late T1R from relapse. T1R continues to be treated with corticosteroids and complications due to iatrogenic treatment remain frequent. This review aims to provide a framework from which to approach the great challenges that still persist in T1R management and debate key issues in order to reduce the distance between basic research and the clinic.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Immunosuppressive Agents/therapeutic use , Leprostatic Agents/therapeutic use , Leprosy/therapy , Mycobacterium leprae/immunology , Animals , Clinical Trials as Topic , Humans , Interferon-gamma/antagonists & inhibitors , Leprostatic Agents/pharmacology , Leprosy/immunology , Transforming Growth Factor beta/antagonists & inhibitors
8.
Rio de Janeiro; s.n; 2012. xx,97 p. graf, tab, ilus, mapas.
Thesis in Portuguese | LILACS | ID: lil-695546

ABSTRACT

A forma lepromatosa da Hanseníase caracteriza-se pela baixa ou ausente resposta imune específica aos antígenos do Mycobacterium leprae e intensa proliferação bacilar. Dentre as células hospedeiras, os macrófagos parecem ter um papel crucial no direcionamento do perfil de resposta ao M. leprae. Muitas das vias de imunossupressão da resposta imune celular parecem estar envolvidas com o metabolismo do ferro e seus carreadores, como a expressão aumentada de IDO em macrófagos lepromatosos e de heme-oxigenase 1 em macrófagos M2. Anteriormente, o nosso grupo demonstrou que macrófagos de pacientes lepromatosos apresentam uma maior expressão do receptor scavenger CD163, quando comparados aos tuberculóides. O CD163 reconhece o complexo Hemoglobina-Haptoglobina e nós hipotetizamos que o M. leprae adaptou-se para aumentara expressão de CD163, a fim de aumentar estoques de ferro em macrófagos, contribuindo para sua persistência. Assim, o objetivo do presente trabalho foi investigar o envolvimento de ferro na imunopatogênese da hanseníase. Nós observamos que biópsias de lesão de pele de pacientes lepromatosos apresentam uma maior expressão de proteínas relacionadas à captação e metabolismo de ferro, assim como uma maior deposição de ferro na forma de ferritina e hemossiderina nos macrófagos espumosos, onde se localizam os bacilos. A adição de ferro exógeno, na forma de tratamento com sulfato ferroso, foi capaz de reduzir a expressão e atividade de indoleamina 2,3-dioxigenase induzida pelo M. leprae em monócitos de doadores saudáveis. A adição de ferro livre também foi capaz de modular a produção de citocinas, aumentando a produção de IL-12p70 e IL-10 em culturas de monócitos, e de IL-6 em culturas de células mononucleares do sangue periférico. O aumento dos receptores CD163 e receptor de transferrina 1 em macrófagos lepromatosos foram associados com o aumento dos estoques de ferro em biópsias de pele de pacientes lepromatosos. Em adição, o tratamento com ferro livre foi capaz aumentar vias proinflamatórias em leucócitos estimulados com M. leprae. Isto indica que a homeostase do ferro no hospedeiro no momento da infecção é importante para a definição do desfecho da Hanseníase, e que o ferro pode ter um papel duplo dependendo do momento e da forma que este está apresentado, podendo criar um ambiente favorável para a micobactéria ou induzindo a produção de citocinas próinflamatórias que podem contribuir para ativação de vias antimicrobianas em macrófagos.


Subject(s)
Communicable Diseases , Immunity , Iron , Iron Metabolism Disorders , Leprosy , Mycobacterium leprae , Parasites
SELECTION OF CITATIONS
SEARCH DETAIL